DERM

NASDAQ 已收盘

Journey Medical Corporation

6.40 USD
+0.10-1.08%
盘后 6.36 -1.70%
2026-08-03
市值
$176.22M
市盈率
EPS
-0.37
股息率
52 周区间
4.31 – 9.56
成交量
163.53K
Beta
1.07
目标价
13.50
52W 低 4.3152W 高 9.56
价格走势

公司简介

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to se...